Grants and Contributions:
Agreement Number:
-
Agreement Value:
$522,880.00
Agreement Date:
Apr 1, 2013 - Mar 31, 2017
Description:
Bortezomib mediated BRCAness in Myeloma cells: novel therapeutic approach combining PARP1-2 and 26S proteasome inhibitors.
Organization:
Canadian Institutes of Health Research
Location:
Calgary, Alberta, CA T2N 1N4
Reference Number:
236-2012-2013-Q4-00674
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2013-14 to 2016-17)
Recipient's Legal Name:
BAHLIS, Nizar J
Research Organization:
University of Calgary